Evidence map›Paper›PMID 32454795›Full record

ArticleMediators of inflammation2020

Notch-Hes1 Signaling Regulates IL-17A

Yanqin Wang, Xinxin Li, Xiaoyun Xing, Haibo Xue, Ruiqun Qi, Hong Ji, Lei Ma

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Natural Modulators of Key Signaling Pathways in Skin Inflammageing.Clinical, cosmetic and investigational dermatology · 2024
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yanqin WangDepartment of Dermatology, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China.
Xinxin LiDepartment of Dermatology, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China.
Xiaoyun XingDepartment of Dermatology, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China.
Haibo XueDepartment of Endocrinology and Metabolism, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China.ORCID https://orcid.org/0000-0002-0495-3349
Ruiqun QiDepartment of Dermatology, The First Affiliated Hospital of China Medical University, 155 North Nanjing Road, Shenyang 110001, China.ORCID https://orcid.org/0000-0002-5856-4584
Hong JiDepartment of Pathology, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China.
Lei MaDepartment of Dermatology, Binzhou Medical University Hospital, 661 Second Huanghe Road, Binzhou 256603, China.ORCID https://orcid.org/0000-0002-8390-3242
Binzhou Medical University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the regulating effect of Notch-Hes1 signaling on IL-17A MATERIALS AND

methodsExperimental mice were randomly divided into control group, model group (5% imiquimod- (IMQ-) treated mice), and intervention group (IMQ and

resultsThe spleen index, IL-17A

Indexed as

AnimalsCytokinesEnzyme-Linked Immunosorbent AssayFlow CytometryImiquimodInflammationInterleukin-17MaleMiceMice, Inbred BALB CPsoriasisReceptors, NotchSignal TransductionSkinSpleenTh17 CellsCytokinesHes1 protein, mouseIl17a protein, mouseImiquimodInterleukin-17Receptors, NotchTranscription Factor HES-1

Identifiers

PMID32454795
PMCPMC7240798
OpenAlexW3025077385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.